In Plenary I, researchers reviewed new insights into the dynamics of autoimmune rheumatic disease, antiphospholipid syndrome, and pregnancy; systemic lupus erythematosus and pulmonary arterial hypertension; gene expression of synovial macrophages in rheumatoid arthritis; and reduced glucocorticoid dosing. Maria Powell, MD, shared the proposed first-ever consensus recommendations on musculoskeletal ultrasound training for Canada.
In this audience-driven Meet the Panel session, featuring Zachary Wallace, MD, MSc, and other experts, participants shared lessons learned and knowledge gaps regarding COVID-19 vaccination among patients with rheumatic disease, drug therapies to treat COVID-19, risk of viral rebound, and more. Dr. Wallace said shared decision-making with patients is the best approach to prevent and…
Experts including Bente Langdahl, MD, PhD, presented three controversial topics in managing osteoporosis in patients, including mitigating bone loss upon discontinuation of denosumab, the use of bone turnover markers, and vitamin D supplementation.
The Great Debates are some of the most anticipated sessions of ACR Convergence. The Adult Great Debate will ask whether polymyalgia rheumatica and giant cell arteritis should be treated with advanced therapies at disease onset. The Pediatric Great Debate will consider whether to initiate early combination therapy or step-up therapy for polyarticular juvenile idiopathic arthritis.
During this highly interactive session, panelists will lead the audience through the evaluation, differential diagnosis, and treatment for a nuanced case of myositis. For the first time, panelists will integrate artificial intelligence in the form of ChatGPT into the process, said moderator Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS.
In Monday’s plenary session, researchers will discuss new developments related to CXCL13+ peripheral helper cells, SGLT2 inhibitor use in patients with lupus, benefits of microbiome transplantation in osteoarthritis, respiratory outcomes in rheumatoid arthritis and interstitial lung disease, split-dosing in rheumatoid arthritis, and the effects of prophylaxis on infections during treatment of granulomatosis with polyangiitis.
Jane Buckner, MD, will discuss the efficacy and limitations of various therapies to manipulate immune response that targets the pathogenic processes and affected organs in autoimmunity while sparing the remainder of the immune response. Antigen-specific therapy provides potential for precision medicine without deleterious effects on patients, but according to Dr. Buckner, researchers must first answer…
Special considerations for vaccination in individuals living with rheumatic diseases have been the subject of several guidelines from medical societies in recent years, such as the ACR’s 2022 Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Kathryn Edwards, MD, will discuss the safety and immunogenicity of pediatric vaccines.